Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-09

Clinical Trial Update: Blood Pressure Lowering in Acute Stroke Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating blood pressure lowering in acute stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Stroke, Acute | Phase 4 | Status: WITHDRAWN